These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23883870)

  • 1. Statin use and fracture risk: can we quantify the healthy-user effect?
    McCandless LC
    Epidemiology; 2013 Sep; 24(5):743-52. PubMed ID: 23883870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
    Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
    Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to statins is associated to fracture risk reduction in elderly people with cardiovascular disease: evidence from the AIFA-I-GrADE observational project.
    Rea F; Bonassi S; Vitale C; Trifirò G; Cascini S; Roberto G; Chinellato A; Lucenteforte E; Mugelli A; Corrao G;
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):775-784. PubMed ID: 28370905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
    Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
    Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and fracture risk. A systematic review.
    Toh S; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):627-40. PubMed ID: 17286319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of statins and risk of fractures in a military health system: a propensity score-matched analysis.
    Ward IM; Mortensen EM; Battafarano DF; Frei CR; Mansi I
    Ann Pharmacother; 2014 Nov; 48(11):1406-14. PubMed ID: 25070396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering agents and the risk of hip fracture in a Medicaid population.
    Ray WA; Daugherty JR; Griffin MR
    Inj Prev; 2002 Dec; 8(4):276-9. PubMed ID: 12460961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects.
    van Rein N; Cannegieter SC; le Cessie S; Rosendaal FR; Reitsma PH; van der Meer FJ; Lijfering WM
    Am J Epidemiol; 2016 May; 183(10):930-6. PubMed ID: 27189329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the association between statin and fracture: a Bayesian consideration.
    Nguyen ND; Wang CY; Eisman JA; Nguyen TV
    Bone; 2007 Apr; 40(4):813-20. PubMed ID: 17178257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis.
    Bykov K; Yoshida K; Weisskopf MG; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):294-300. PubMed ID: 27527987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and hip fracture risk in men: a population-based case-control study.
    Adams AL; Shi JM; Reynolds K; Haque R; Cheetham TC; Kawatkar AA; Fithian DC; Jacobsen SJ
    Ann Epidemiol; 2015 Nov; 25(11):844-8. PubMed ID: 26475981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
    Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
    J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring association between statin use and breast cancer risk: an updated meta-analysis.
    Islam MM; Yang HC; Nguyen PA; Poly TN; Huang CW; Kekade S; Khalfan AM; Debnath T; Li YJ; Abdul SS
    Arch Gynecol Obstet; 2017 Dec; 296(6):1043-1053. PubMed ID: 28940025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hip fracture risk in statin users--a population-based Danish case-control study.
    Rejnmark L; Olsen ML; Johnsen SP; Vestergaard P; Sørensen HT; Mosekilde L
    Osteoporos Int; 2004 Jun; 15(6):452-8. PubMed ID: 15205716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and fracture risk: study of a US veterans population.
    Scranton RE; Young M; Lawler E; Solomon D; Gagnon D; Gaziano JM
    Arch Intern Med; 2005 Sep; 165(17):2007-12. PubMed ID: 16186471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients.
    Nichols R; Hopman WM; Morton AR; Harman GJ; Holden RM
    Hemodial Int; 2008 Apr; 12(2):275-9. PubMed ID: 18394063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
    Hatzigeorgiou C; Jackson JL
    Osteoporos Int; 2005 Aug; 16(8):990-8. PubMed ID: 15744453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    An T; Hao J; Sun S; Li R; Yang M; Cheng G; Zou M
    Osteoporos Int; 2017 Jan; 28(1):47-57. PubMed ID: 27888285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.